| View |
|
DR-XY42792
|
Olopatadine (hydrochloride)
|
Icool
|
1 mg/mL (0.1%)
|
Ophthalmic Solution
|
-
|
Aju Pharm Co., Ltd.
|
Korea
|
Automatic Renewal
|
01 June 2021
|
10 October 2025
|
| View |
|
DR-XY42794
|
Ascorbic Acid + Zinc (as Sulfate Monohydrate)
|
Efica-cee
|
100mg/10mg per 5mL
|
Syrup
|
Vitamin and Mineral
|
Sydenham Laboratories, Inc.
|
Philippines
|
Renewal
|
10 August 2023
|
11 October 2028
|
| View |
|
DR-XY42796
|
Ursodeoxycholic Acid
|
Ursomax
|
300 mg
|
Tablet
|
Bile Salt
|
Hankook Korus Pharm. Co., Ltd.
|
Korea
|
Renewal
|
23 August 2023
|
11 October 2028
|
| View |
|
DR-XY42800
|
Ganciclovir (as sodium)
|
Amcivir
|
500 mg
|
Lyophilized Powder for Injection
|
Antiviral
|
Hainan Poly Pharmaceutical Co., Ltd.
|
China
|
Automatic Renewal
|
12 September 2022
|
11 October 2027
|
| View |
|
DR-XY42801
|
Chlorphenamine Maleate + Phenylephrine Hydrochloride
|
Cynosal
|
500 mcg/1 mg per mL
|
Syrup (Oral Drops)
|
Antihistamine/Nasal Decongestant
|
Lejal Laboratories Inc.
|
Philippines
|
Renewal
|
11 January 2019
|
11 October 2028
|
| View |
|
DR-XY42804
|
Meclizine
|
None
|
25 mg
|
Chewable Tablet
|
-
|
Vonwelt, Inc.
|
Philippines
|
-
|
18 December 2020
|
11 October 2025
|
| View |
|
DR-XY42806
|
Co-Amoxiclav
|
Monamox-CL 625
|
500 mg / 125 mg
|
Film Coated Tablet
|
Antibacterial (Combination of Penicillin and beta-
lactamase inhibitor)
|
Zee Laboratories Limited
|
India
|
Initial
|
30 August 2023
|
30 August 2028
|
| View |
|
DR-XY42830
|
FLUCONAZOLE
|
MEDOFLUCON
|
50 mg
|
Capsule
|
Antifungal
|
Medochemie Ltd. (Central Factory)
|
Cyprus
|
Renewal
|
24 October 2023
|
17 October 2028
|
| View |
|
DR-XY42834
|
Omeprazole + Sodium Bicarbonate
|
Risek Insta
|
20mg /1680mg
|
Powder For Oral Suspension
|
Proton Pump Inhibitor
|
Getz Pharma (Pvt) Ltd.
|
Pakistan
|
Renewal
|
26 April 2023
|
18 October 2028
|
| View |
|
DR-XY42835
|
Omeprazole + Sodium Bicarbonate
|
Risek Insta
|
40mg / 1680mg
|
Powder For Oral Suspension
|
Proton Pump Inhibitor
|
Getz Pharma (Pvt) Ltd.
|
Pakistan
|
Renewal
|
26 April 2023
|
18 October 2028
|
| View |
|
DR-XY42843
|
Potassium Chloride
|
Kaltrol
|
100mg/mL (1.34 mEq/mL)
|
Concentrate Solution For Injection (Iv Infusion)
|
Electrolyte Replenisher
|
Zhejiang Tianrui Pharmaceutical Co., Ltd.
|
China
|
Renewal
|
01 August 2023
|
18 October 2028
|
| View |
|
DR-XY42850
|
Acevon
|
Paracetamol
|
250 mg / 5 mL
|
Syrup
|
-
|
Vonwelt Inc.
|
Philippines
|
-
|
14 May 2021
|
14 April 2026
|
| View |
|
DR-XY42851
|
Clonidine Hydrochloride
|
Catamed
|
150 mcg
|
Tablet
|
Antiadrenergic (Centrally Acting antihypertensive)
|
Lloyd Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
12 July 2023
|
18 October 2028
|
| View |
|
DR-XY42858
|
Paracetamol + Phenylephrine HCl + Chlorpheniramine Maleate
|
Nagelin (Reformulated)
|
325 mg/25mg/2mg
|
Capsule
|
Analgesic/Antipyretic/Decongestant/Antihistamine
|
La Croesus Pharma, Inc.
|
Philippines
|
Renewal
|
24 October 2023
|
23 October 2028
|
| View |
|
DR-XY42867
|
Azithromycin (as dihydrate)
|
Trozin
|
250mg
|
Film-Coated Tablet
|
Antibacterial (Macrolide)
|
Mercury Laboratories Ltd.
|
India
|
Renewal
|
21 March 2023
|
24 October 2028
|
| View |
|
DR-XY42871
|
Doxofylline
|
Dilatair
|
400 mg
|
Tablet
|
Drug for Obstructive Airway Disease (Xanthines)
|
Ajanta Pharma Ltd.
|
India
|
Renewal
|
04 August 2023
|
24 November 2028
|
| View |
|
DR-XY42872
|
Rebamipide
|
Remasta
|
100 mg
|
Film Coated Tablet
|
Drugs for Peptic Ulcer and Gastroesophageal Reflux Disease (GERD)
|
Myungmoon Pharmaceutical Co., Ltd.
|
Korea
|
Renewal
|
25 July 2023
|
25 October 2028
|
| View |
|
DR-XY42877
|
Paracetamol + Phenylephrine Hydrochloride
|
No-Drowse Decolgen
|
500 mg/ 10 mg
|
Tablet
|
Analgesic/Antipyretic/Nasal Decongestant
|
PT. Medifarma Laboratories
|
Indonesia
|
Renewal
|
26 October 2023
|
24 October 2028
|
| View |
|
DR-XY42878
|
Cefuroxime (as sodium)
|
Medzyme
|
1.5 G
|
Powder For Injection
|
Antibacterial (Cephalosporin)
|
Phil Inter Pharma Co., Ltd.
|
Vietnam
|
Renewal
|
10 August 2018
|
29 October 2028
|
| View |
|
DR-XY42886
|
Ampicillin (as Sodium)
|
Ampiral
|
1g
|
Powder for Injection (IM/IV)
|
Antibacterial
|
CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.
|
China
|
Automatic Renewal
|
09 October 2021
|
31 October 2026
|